Commentaries, Letters, etc
Altman DG, Simera I. Responsible reporting of health research studies: transparent, complete, accurate and timely. J Antimicrob Chemother 2010; 65: 1-3.
Boutron I, Ravaud P, Altman DG. Randomized controlled trials with statistically nonsignificant results. JAMA 2010; 304: 965.
Habib AG, Nasidi A, Alder N, Juszczak E, Theakston RD, Warrell DA; for EchiTAb Study Group Nigeria-UK. Response to a letter from J-P Chippaux and L Boyer entitled: “The 3 + 3 dose escalation design is not appropriate for antivenom dose finding.” Toxicon 2010; 55: 1410-1411.
Hemingway H, Riley RD, Altman DG. Improving prognosis research. BMJ http://www.bmj.com/cgi/eletters/340/feb17_2/c703#234364
Hopewell S. Standards to improve the reporting of clinical trials in acupuncture. Acupunct Med 2010; 28: 63.
Schriger DL, Altman DG. Inadequate post-publication review of medical research. BMJ 2010; 341: c3803.
Schulz
KF, Altman DG, Moher D. Re: Testing
for blinding is the only way to determine whether a trial is blind. BMJ 27 May 2010
http://www.bmj.com/cgi/eletters/340/mar23_1/c332#236273
Simera I, Altman DG, Moher D, Schulz KF, Hoey J. La red EQUATOR: facilitando la comunicación transparente y precisa de la investigación sanitaria. In: Jiménez Villa J, Argimon Pallàs JM, Martín Zurro A, Vilardell Tarrés M (eds). Publicación cientifica biomedical: Cómo escribir y publicar un artículo de investigación. Barcelona: Elsevier, 2010: 265-271.
Simera I, Moher D, Hirst A, Hoey J, Schulz KF, Altman DG. Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network. BMC Med 2010; 8: 24.
Vedula SS, Altman DG. Effect size estimation as an essential component of statistical analysis. Arch Surg 2010;145:401-402.
Williamson
PR, Kirkham JJ, Dwan KM, Altman DG,
Gamble C, Dodd S, Smyth R. Re: Under-estimating the impact? BMJ 20 May 2010
http://www.bmj.com/cgi/eletters/340/feb15_1/c365#236037
